Invention Grant
- Patent Title: Pharmaceutical composition containing silybin and ve
-
Application No.: US15560573Application Date: 2016-03-22
-
Publication No.: US11318112B2Publication Date: 2022-05-03
- Inventor: He Sun , Xijun Yan , Naifeng Wu , Kaijing Yan , Yonghong Zhu , Shunnan Zhang , Xiaolin Bai , Xiaohui Ma , Yi He , Ting Li , Lei Li
- Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.
- Applicant Address: CN Tianjin
- Assignee: TASLY PHARMACEUTICAL GROUP CO., LTD.
- Current Assignee: TASLY PHARMACEUTICAL GROUP CO., LTD.
- Current Assignee Address: CN Tianjin
- Agency: BakerHostetler
- Priority: CN201510128638.8 20150323
- International Application: PCT/CN2016/077035 WO 20160322
- International Announcement: WO2016/150376 WO 20160929
- Main IPC: A61K31/357
- IPC: A61K31/357 ; A61K36/82 ; A61K47/24 ; A61K9/48 ; A61K31/205 ; A61P1/16 ; A61K9/16 ; A61K31/355 ; A61K31/683 ; A61K9/08 ; A61K36/488
Abstract:
A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Pu'er tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases.
Public/Granted literature
- US20180050015A1 PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN AND VE Public/Granted day:2018-02-22
Information query
